Share Price, page-763

Unfortunate as it is, I'm not surprised to see NEU shares heading down, and if I'm honest I expect them to drop even lower to around $2.50-2.80. With a company like Neuren that has great prospects on the horizon but not much intrinsic value, while an announcement about the FDA submission maybe forthcoming there is really nothing going for Neuren to prop up the share price. Another aspect I've seen before in other stocks is the initial rush to buy stock in a company that has been languishing price or progress wise for some time, retail investors get sucked in to the vortex (like myself) with the hope you have timed buying the stock correctly and that the sp increase will be sustained. But now it appears the tide is going out for Neuren, I don't think it will ever go down to its previous average price ($1.74?) but one should expect this retracement to continue especially in light of financial market volatility and rising inflation.